Similar articles for PMID: 24134154

Year	Number of Results
1986	1
1990	1
1992	1
1994	1
1995	1
1996	1
1997	1
1998	3
1999	1
2000	4
2001	4
2002	1
2003	3
2004	7
2005	7
2006	10
2007	4
2008	3
2009	3
2010	3
2011	11
2012	9
2013	17
2014	15
2015	11
2016	16
2017	21
2018	18
2019	25
2020	27
2021	23
2022	23
2023	10
2024	0

1

Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects.

Vipperla K, O'Keefe SJ. Vipperla K, et al. Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):683-7. doi: 10.1586/17474124.2013.842894. Epub 2013 Oct 17. Expert Rev Gastroenterol Hepatol. 2013. PMID: 24134154 Review.

2

Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.

Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghöfer P. Jeppesen PB, et al. Clin Nutr. 2013 Oct;32(5):713-21. doi: 10.1016/j.clnu.2013.03.016. Epub 2013 Mar 28. Clin Nutr. 2013. PMID: 23587733 Clinical Trial.

3

Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.

Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C. Jeppesen PB, et al. Gastroenterology. 2018 Mar;154(4):874-885. doi: 10.1053/j.gastro.2017.11.023. Epub 2017 Nov 22. Gastroenterology. 2018. PMID: 29174926 Free article. Clinical Trial.

4

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.

Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ. Jeppesen PB, et al. Gut. 2011 Jul;60(7):902-14. doi: 10.1136/gut.2010.218271. Epub 2011 Feb 11. Gut. 2011. PMID: 21317170 Free PMC article. Clinical Trial.

5

Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.

Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B. Jeppesen PB, et al. Gastroenterology. 2012 Dec;143(6):1473-1481.e3. doi: 10.1053/j.gastro.2012.09.007. Epub 2012 Sep 11. Gastroenterology. 2012. PMID: 22982184 Clinical Trial.

6

New approaches to the treatments of short bowel syndrome-associated intestinal failure.

Jeppesen PB. Jeppesen PB. Curr Opin Gastroenterol. 2014 Mar;30(2):182-8. doi: 10.1097/MOG.0000000000000046. Curr Opin Gastroenterol. 2014. PMID: 24406477 Review.

7

Experience with teduglutide treatment for short bowel syndrome in clinical practice.

Pevny S, Maasberg S, Rieger A, Karber M, Blüthner E, Knappe-Drzikova B, Thurmann D, Büttner J, Weylandt KH, Wiedenmann B, Müller VA, Bläker H, Pascher A, Pape UF. Pevny S, et al. Clin Nutr. 2019 Aug;38(4):1745-1755. doi: 10.1016/j.clnu.2018.07.030. Epub 2018 Aug 2. Clin Nutr. 2019. PMID: 30145039

8

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Yazbeck R. Yazbeck R. Curr Opin Mol Ther. 2010 Dec;12(6):798-809. Curr Opin Mol Ther. 2010. PMID: 21154171

9

Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.

Jeppesen PB. Jeppesen PB. JPEN J Parenter Enteral Nutr. 2014 May;38(1 Suppl):45S-52S. doi: 10.1177/0148607114526241. Epub 2014 Mar 10. JPEN J Parenter Enteral Nutr. 2014. PMID: 24615689 Review.

10

Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.

Tappenden KA, Edelman J, Joelsson B. Tappenden KA, et al. J Clin Gastroenterol. 2013 Aug;47(7):602-7. doi: 10.1097/MCG.0b013e3182828f57. J Clin Gastroenterol. 2013. PMID: 23426461 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

247 results

Results by year